Updated:
Yangming Capital
Yangming Capital is an investment company focused on biotechnology, healthcare, and other areas. It has made 7 investments to date. The company's most recent...
Yangming Capital
Yangming Capital is an investment company focused on biotechnology, healthcare, and other areas. It has made 7 investments to date. The company's most recent investment was in Zhijian Life, a Seed VC investment made on August 03, 2023.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Wuxi
Corporate office
Wuxi, Jiangsu, China
Sector focus
Frequently asked questions
What investment stages does Yangming Capital target?
Yangming Capital focuses on the earliest stages of company formation, deploying capital in seed and start-up rounds. It typically acts as a first institutional investor for founders, entering before conventional Series A funds. The firm's mandate is oriented toward early-stage venture, with no public indication of later-stage growth equity or buyout activity.
How does Yangming Capital's location in Wuxi influence its investment approach?
Wuxi sits in the Yangtze River Delta, one of the most concentrated advanced manufacturing regions globally. Yangming Capital uses this location to connect hard-tech portfolio companies with prototyping facilities, component suppliers, and skilled labor markets in cities like Suzhou and Changzhou. This geographic embed provides a practical, non-financial value-add by shortening hardware development cycles.
Which sectors does Yangming Capital prioritize?
The firm's investment emphasis is on hard-technology sectors that align with the industrial base of Jiangsu province. Known interests include industrial technology, enterprise software, AI and machine learning, robotics, and energy transition. It does not publicly list consumer internet, fintech, or platform businesses as areas of focus.
Does Yangming Capital participate in fund commitments or only direct deals?
Yangming Capital operates as a direct investment firm writing checks into individual companies at the seed and start-up stage. There is no public record of the firm acting as a fund-of-funds, participating in GP commitments, or managing separate pooled fund vehicles on behalf of external LPs.
Who runs investment decisions at Yangming Capital?
The firm does not publicly disclose its founder, investment committee members, or managing partners on its website or social media channels. This opacity is not unusual for an early-stage Chinese fund operating outside the major venture hubs, often indicating a closely held partnership structure with decisions made by a small group of founding investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: